KFDA approves sorafenib for treatment of hepatocellular carcinoma
The oral multikinase inhibitor sorafenib significantly extended overall survival by 44 percent, compar...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
